Publications
5539 Results
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:636(#2558)
- Year
- 2003
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-8805, SWOG-9019, SWOG-9416, SWOG-9509
Time from treatment to subsequent diagnosis of brain metastases in Stage III non-small cell lung cancer (NSCLC): a retrospective review by the Southwest Oncology Group (SWOG)
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:403(#1619)
- Year
- 2003
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S0031
Evaluation of ZD1839 for advanced transitional cell carcinoma (TCC) of the urothelium: a Southwest Oncology Group trial
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:5(#16)
- Year
- 2003
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9347 (INT-0142) (E3193)
Phase III comparison of tamoxifen versus tamoxifen with ovarian ablation in premenopausal women with axillary node-negative receptor-positive breast cancer < 3 cm
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:6(#19)
- Year
- 2003
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-9061 (EST-2190) (INT-0121)
Phase III study of conventional adjuvant chemotherapy with or without high-dose chemotherapy and autologous stem cell transplantation in patients with stage II and III breast cancer at high risk of recurrence (INT 0121)
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:19(#73)
- Year
- 2003
- Research Committee(s)
- Breast
- Study Number(s)
- E2197
LVEF assessment of adjuvant doxorubicin/cyclophosphamide (AC) vs doxorubicin/docetaxel (AT) in early stage breast cancer: cardiac safety results of ECOG 2197.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:5(#15)
- Year
- 2003
- Research Committee(s)
- Breast
- Study Number(s)
- SWOG-8851 (INT-0101) (EST-5188)
Chemohormonal therapy in premenopausal node-positive, receptor-positive breast cancer: an Eastern Cooperative Oncology Group phase III intergroup trial (E5188, INT-0101).
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:620(#2493)
- Year
- 2003
- Research Committee(s)
- Lung
- Study Number(s)
- S9714
EGFR, HER2 and ERB-B pathway activation in bronchioloalveolar carcinoma (BAC): analysis of SWOG 9417 and lung spore tissue samples.
- Journal / Conference
- Proc of the American Society of Clinical Oncology 22:820(#3297)
- Year
- 2003
- Research Committee(s)
- Sarcoma
- Study Number(s)
- S9802
Phase II trial of gemcitabine as first line chemotherapy in patients with metastatic or unresectable soft tissue sarcomas (STS).
- Journal / Conference
- Journal of Clinical Oncology 21(4):607-614
- Year
- 2003
- Research Committee(s)
- Lymphoma
- Study Number(s)
- SWOG-8952 (INT-0111) (CALGB-8952) (EST-5489)
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an Intergroup trial
- Journal / Conference
- Proc of the American Association for Cancer Research 44:#3807
- Year
- 2003